Skip to content

Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease

Pilot Study of Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01865097
Enrollment
50
Registered
2013-05-30
Start date
2013-06-30
Completion date
Unknown
Last updated
2014-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Imagery, Pain, Depression, Non-Motor

Brief summary

Parkinson's disease patients may have severe non-motor symptoms. A common and troublesome non-motor symptom is pain. Currently these symptoms are treated with medication with limited success. Our study aims to determine whether relaxation guided imagery can alleviate pain in Parkinson's disease patients.

Detailed description

Parkinson's disease patients with severe pain without dementia will participate in this study aimed to examine a possible beneficial effect of relaxation guided imagery on pain. This will be a phase I, controlled, single blind and randomized efficacy study in 2 parallel groups. The study will include a baseline assessment of pain severity where after the intervention group will undergo relaxation guided imagery and the control group will listen to relaxing music. After these relaxation session patients will receive a CD with either relaxation guided imagery or relaxing music to listen to at home. Pain severity will be recorded for the following 6 weeks.

Interventions

An individualized relaxation guided imagery session will be conducted. After the session patients will be given a CD with the relaxation guided imagery and asked to listen to it at home.

BEHAVIORALRelaxing music

An individualized session of listening to relaxing music will be conducted. After the session patients will be given a CD with the relaxing music and asked to listen to it at home.

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with idiopathic Parkinson's disease suffering from significant pain.

Exclusion criteria

* Dementia * Hearing impairment

Design outcomes

Primary

MeasureTime frameDescription
Pain scores on the visual analog scale6 weeksNumeric rating scale after relaxation guided imagery as compared with baseline

Secondary

MeasureTime frameDescription
The brief Pain Inventory6 weeksThe brief Pain Inventory after relaxation guided imagery as compared with baseline

Other

MeasureTime frameDescription
Health status measured by Parkinson's Disease Questionnaire 39(PDQ39)6 weeksPDQ39 after relaxation guided imagery as compared with baseline
Depression scores on Beck Depression Inventory (BDI)6 weeeksBDI after relaxation guided imagery as compared with baseline
Non-motor symptom screening questionaire6 weeksNon-motor symptom screening questionaire after relaxation guided imagery as compared with baseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026